Nabriva Therapeutics plc NBRV
Set alert
At close · Jul 31
52-week range unavailable
- Open
- 1.45
- Prev close
- 1.42
- Mkt cap
- 4.55M
- Vol
- 706.54K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.35
- High
- 1.90
- Forward P/E
- -0.18
- Beta
- 1.55
- Short ratio
- 6.12
- Inst. own
- 9.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 1.57
- 200-d avg
- 1.83
- 1y target
- 0.00
News
9 months ago defenseworld.net
Aadi Bioscience (NASDAQ:AADI) versus Nabriva Therapeutics (NASDAQ:NBRV) Head-To-Head Analysis
Profitability This table compares Aadi Bioscience and Nabriva Therapeutics' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Aadi Bioscience -246.06%…
10 months ago defenseworld.net
Nabriva Therapeutics (NASDAQ:NBRV) versus Virpax Pharmaceuticals (NASDAQ:VRPX) Head-To-Head Contrast
Volatility and Risk Virpax Pharmaceuticals has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Comparatively, Nabriva Therapeutics has a beta of 1.53,…
3 years ago investorplace.com
7 Stocks to Sell as Banks Melt Down
Peruse the Internet for investment guidance and you're likely to hear the adage that you shouldn't consider stocks to sell when faced with volatility. Rather, you should buy up assets and securities…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows.
-
3 years ago benzinga.com
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 71 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 75 companies set new 52-week lows.
3 years ago zacks.com
Nabriva (NBRV) Posts Positive Data From Cystic Fibrosis Study
Nabriva (NBRV) posts positive top-line data from the phase I study evaluating oral and intravenous Xenleta (lefamulin) in adult patients with cystic fibrosis. Shares down.
3 years ago marketwatch.com
Nabriva's stock is up after sharing antibiotic news
Shares of Nabriva Therapeutics Plc NBRV, were up 13.8% in premarket trading on Monday after the company said in a news release it had positive data from a Phase 1 clinical trial assessing its…
3 years ago seekingalpha.com
Nabriva Therapeutics plc (NBRV) Q3 2022 Earnings Call Transcript
Nabriva Therapeutics plc (NASDAQ:NBRV ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Daniel Dolan - CFO Theodore Schroeder - CEO Conference Call Participants…
-
3 years ago benzinga.com
Earnings Scheduled For November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
3 years ago globenewswire.com
Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022
DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 930 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 1076 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 340 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 429 stocks made new 52-week lows.
-
4 years ago benzinga.com
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
4 years ago investorplace.com
What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?
Source: iQoncept / Shutterstock Nabriva Therapeutics (NASDAQ: NBRV ) stock caught the attention of traders on Friday after shares surged in price this morning. However, not all is as it seems.
-
4 years ago benzinga.com
US Stocks Open Lower; Dow Tumbles 300 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 300 points on Friday.
4 years ago pennystocks.com
Buying Penny Stocks Today? What You Need to Know
Here's what you need to know about trading penny stocks on September 16th The post Buying Penny Stocks Today? What You Need to Know appeared first on Penny Stocks to Buy, Picks, News and Information…
4 years ago pulse2.com
Nabriva Therapeutics (NBRV) Stock: 1-For-25 Reverse Stock Split Announced
Nabriva Therapeutics (NBRV) announces it will effect a 1-for-25 reverse stock split. These are the details.
4 years ago globenewswire.com
Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
4 years ago zacks.com
All You Need to Know About Nabriva Therapeutics AG (NBRV) Rating Upgrade to Buy
Nabriva Therapeutics AG (NBRV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 168 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 297 companies achieved new lows for the year.
4 years ago globenewswire.com
Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
4 years ago seekingalpha.com
Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2022 Results - Earnings Call Transcript
Nabriva Therapeutics plc (NASDAQ:NBRV ) Q2 2022 Results Conference Call August 3, 2022 4:30 PM ET Company Participants Dan Dolan - CFO Ted Schroeder - CEO Conference Call Participants Carl Byrnes -…
-
4 years ago benzinga.com
Earnings Scheduled For August 3, 2022
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.
4 years ago globenewswire.com
Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022
DUBLIN, Ireland and FORT WASHINGTON, Pa., July 20, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 588 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 269 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 540 companies set new 52-week lows.
4 years ago globenewswire.com
Nabriva Therapeutics to Present at the H.C. Wainwright Global Investment Conference
DUBLIN, Ireland, May 13, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective…
4 years ago seekingalpha.com
Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q1 2022 Results - Earnings Call Transcript
Nabriva Therapeutics plc (NASDAQ:NBRV ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Dan Dolan - Chief Financial Officer Ted Schroeder - Chief Executive Officer…
-
4 years ago benzinga.com
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
4 years ago globenewswire.com
Nabriva Therapeutics to Report First Quarter 2022 Financial Results and Recent Corporate Highlights on May 5, 2022
DUBLIN, Ireland and FORT WASHINGTON, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 213 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 431 companies hit new 52-week lows.
4 years ago seekingalpha.com
Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call Transcript
Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call Transcript
-
4 years ago benzinga.com
Earnings Scheduled For March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 729 companies set new 52-week lows.
-
4 years ago benzinga.com
63 Biggest Movers From Yesterday
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
-
4 years ago benzinga.com
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their…
-
4 years ago benzinga.com
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
-
4 years ago benzinga.com
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
-
5 years ago benzinga.com
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
-
5 years ago benzinga.com
60 Biggest Movers From Yesterday
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related logistics assets.
-
5 years ago benzinga.com
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Asensus Surgical, Inc. (NYSE: ASXC) shares surged 34.4% to $2.7282. HC Wainwright & Co. initiated coverage on Asensus Surgical with a Buy rating and announced a price target of $4.